Sodium glucose cotransporter 2 inhibitors and the risk of respiratory outcomes among patients with type 2 diabetes: A nationwide cohort study

被引：0
|
作者：
Jeong, Han Eol [1 ]
Park, Sohee [2 ]
Noh, Yunha [3 ]
Filion, Kristian [4 ]
Yu, Oriana Hoi Yun [4 ]
Jang, Seung Hun [5 ]
Shin, Ju-Young [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Pharm, Seoul, South Korea
[2] SKKU, Sch Pharm, Seoul, South Korea
[3] Sungkunkwan Univ, Seoul, South Korea
[4] McGill Univ, Montreal, PQ, Canada
[5] Hallym Univ, Coll Med, Hallym Univ Sacred Heart Hosp, Dept Internal Med, Chunchon, South Korea
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
728
引用
收藏
页码：333 / 334
页数：2
相关论文
共 50 条
  • [21] Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
    Eroglu, Talip E.
    Coronel, Ruben
    Souverein, Patrick C.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (04) : 289 - 295
  • [22] Assessing the Risk for Gout With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes A Population-Based Cohort Study
    Fralick, Michael
    Chen, Sarah K.
    Patorno, Elisabetta
    Kim, Seoyoung C.
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (03) : 186 - +
  • [23] Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study
    Kim, Min
    Ha, Kyoung Hwa
    Lee, Junyoung
    Park, Sangshin
    Oh, Kyeong Seok
    Bae, Dae-Hwan
    Lee, Ju Hee
    Kim, Sang Min
    Choi, Woong Gil
    Hwang, Kyung-Kuk
    Kim, Dong-Woon
    Cho, Myeong-Chan
    Kim, Dae Jung
    Bae, Jang-Whan
    KOREAN CIRCULATION JOURNAL, 2024, 54 (05) : 256 - 267
  • [24] Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
    Ueda, Peter
    Svanstrom, Henrik
    Melbye, Mads
    Eliasson, Bjorn
    Svensson, Ann-Marie
    Franzen, Stefan
    Gudbjornsdottir, Soffia
    Hveem, Kristian
    Jonasson, Christian
    Pasternak, Bjorn
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [25] Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Retinal Vein Occlusion among Patients with Type 2 Diabetes: A Propensity Score-Matched Cohort Study
    Lee, Min-Kyung
    Han, Kyungdo
    Kwon, Hyuk-Sang
    Roh, Young-Jung
    DIABETES, 2021, 70
  • [26] Association of sodium-glucose cotransporter 2 inhibitors with post-discharge outcomes in patients with acute heart failure with type 2 diabetes: a cohort study
    Park, Sohee
    Jeong, Han Eol
    Lee, Hyesung
    You, Seng Chan
    Shin, Ju-Young
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [27] Association of sodium-glucose cotransporter 2 inhibitors with post-discharge outcomes in patients with acute heart failure with type 2 diabetes: a cohort study
    Sohee Park
    Han Eol Jeong
    Hyesung Lee
    Seng Chan You
    Ju-Young Shin
    Cardiovascular Diabetology, 22
  • [28] Efficacy of sodium glucose cotransporter 2 inhibitors as an adjunct treatment for patients with diabetes type 2
    Pujante, Pedro
    Ares, Jessica
    Macia, Carmen
    Rodriguez Escobedo, Racil
    Menendez, Edelmiro
    Delgado, Elias
    MEDICINA CLINICA, 2019, 152 (11): : 438 - 441
  • [29] Impact of Sodium Glucose Cotransporter 2 Inhibitors on Weight in Patients With Type 2 Diabetes Mellitus
    Barnett, Anthony H.
    POSTGRADUATE MEDICINE, 2013, 125 (05) : 92 - 100
  • [30] Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Dementia in People with Type 2 Diabetes-A Population-Based Cohort Study
    Tang, Huilin
    Shaaban, C. Elizabeth
    Wu, Yonghui
    Magoc, Tanja
    Donahoo, William T.
    Dekosky, Steven T.
    Bian, Jiang
    Guo, Jingchuan
    DIABETES, 2023, 72
12345